SERA (seraprognostics.com) שולי רווח גולמי

SERA (Sera Prognostics, Inc.) - סמל מסחרי של החברה

Sera Prognostics (SERA) currently demonstrates financial resilience through its gross margin, while the -836.50 metric indicates a status of operational efficiency. Geopolitical tensions and sanctions are hindering global research, slowing the launch of new tests. Simultaneously, the company is implementing ESG standards to optimize waste utilization. Rising sales of the PreTRM system create potential for the product's future inclusion in insurance programs.

SERA (Sera Prognostics Inc.) היסטוריית רווחיות גולמית מ-04.07.2022 עד 19.11.2026

פילוחים אנליטיים ודוחות נתונים של חברת Sera Prognostics Inc. (SERA)

הערכת שווי פונדמנטלית:SERA (Sera Prognostics Inc.)
מוצרים מיוצרים של Sera Prognostics, Inc.

Gross margin measures the portion of revenue remaining after direct production costs, allowing investors to assess cost management efficiency and the product's pricing power. By analyzing the effective gross margin trend, one can diagnose the resilience of the Sera Prognostics (SERA) model during the expansion of blood biomarker tests and the scaling of insurance coverage within US medical standards.